Soleus Private Equity group reports shared beneficial ownership of presently exercisable warrants to purchase 391,952 shares of CalciMedica, Inc. common stock. The filings show 195,976 warrants held by Soleus Private Equity Fund III and by Soleus Capital Master Fund, producing entity-level totals of 391,952 shares and a reported 2.4% ownership figure for certain Soleus entities. The percentage calculations use 15,743,916 shares outstanding as of February 25, 2026 per the Issuer's cited Form 10-K. Filers disclaim direct beneficial ownership other than for Section 13(d) purposes and attribute holdings to affiliated funds and managers.
Positive
None.
Negative
None.
Key Figures
Presently exercisable warrants (combined):391,952 sharesPresently exercisable warrants (per fund):195,976 sharesShares outstanding used in calculation:15,743,916 shares+2 more
5 metrics
Presently exercisable warrants (combined)391,952 sharesaggregate warrants held by Soleus entities
Presently exercisable warrants (per fund)195,976 shareswarrants reported for Soleus Private Equity Fund III and for Soleus Capital Master Fund
Shares outstanding used in calculation15,743,916 sharesas of <date>February 25, 2026</date> per the cited Form 10-K
Ownership percentage (combined entities)2.4%reported percent for Soleus Capital Management, L.P., Soleus GP, LLC and Guy Levy
Ownership percentage (single fund)1.2%reported percent for Soleus Private Equity Fund III and Soleus Capital Master Fund
"The number of shares reported... consists of presently exercisable warrants to purchase up to 195,976 shares"
shared dispositive powerregulatory
"Shared Dispositive Power 195,976.00"
beneficial ownershipregulatory
"Each of ... disclaims beneficial ownership of these shares held by Soleus PE"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Section 13(d)regulatory
"for the purpose of determining their obligations under Section 13(d) of the Securities Exchange Act"
What did Soleus disclose about CALC (CalciMedica) ownership?
Soleus disclosed shared beneficial ownership of presently exercisable warrants to purchase 391,952 shares. The filing attributes 195,976 warrants to each fund and reports a 2.4% ownership figure for combined Soleus entities.
How is the 2.4% ownership percentage calculated for CALC?
The 2.4% percentage is calculated using 15,743,916 shares outstanding as of February 25, 2026, as cited from CalciMedica's Form 10-K cover. The filing states the calculation verbatim.
Are these shares common stock or warrants for CALC?
The reported holdings consist of presently exercisable warrants to purchase Common Stock, not currently outstanding common shares. The filing expressly describes the reported numbers as warrants exercisable into common stock.
Who in the Soleus group is linked to the CALC holdings?
The filing lists multiple affiliated filers: Soleus Private Equity Fund III, Soleus Capital Master Fund, Soleus Capital Management, related GP entities, and Guy Levy as managing member. Affiliates disclaim beneficial ownership except for Section 13(d) purposes.
Does Soleus claim sole voting or dispositive power over the CALC warrants?
No. The cover rows show 0 sole voting power and 0 sole dispositive power; reported control is listed as shared voting and shared dispositive power for the specified warrant amounts.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 4)
CALCIMEDICA, INC.
(Name of Issuer)
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
38942Q202
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
38942Q202
1
Names of Reporting Persons
Soleus Private Equity Fund III, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
195,976.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
195,976.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
195,976.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.2 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus Private Equity Fund III, L.P. ("Soleus PE"). Soleus Private Equity GP III, LLC ("Soleus PE GP") is the sole general partner of Soleus PE, Soleus PE GP III, LLC is the sole manager of Soleus PE GP, Soleus Capital Management, L.P. ("SCM") is the investment manager for Soleus PE and for Soleus Capital Master Fund, L.P. ("Master Fund"), and Soleus GP, LLC ("Soleus GP") is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP III, LLC and Soleus GP. Each of Mr. Levy, Soleus PE GP III, LLC, Soleus PE GP, SCM and Soleus GP disclaims beneficial ownership of these shares held by Soleus PE other than for the purpose of determining their obligations under Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The number of shares reported in the table above consists of presently exercisable warrants to purchase up to 195,976 shares of the common stock ("Common Stock") of CalciMedica, Inc. (the "Issuer").
(3) The percentage set forth in row 11 is calculated based upon 15,743,916 shares of Common Stock outstanding as of February 25, 2026, as set forth on the cover of the Issuer's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 that was filed with the Securities and Exchange Commission on March 3, 2026 (the "Form 10-K").
SCHEDULE 13G
CUSIP Number(s):
38942Q202
1
Names of Reporting Persons
Soleus Private Equity GP III, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
195,976.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
195,976.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
195,976.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.2 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus PE. Soleus PE GP is the sole general partner of Soleus PE, Soleus PE GP III, LLC is the sole manager of Soleus PE GP, SCM is the investment manager for Soleus PE and for Master Fund, and Soleus GP is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP III, LLC and Soleus GP. Each of Mr. Levy, Soleus PE GP III, LLC, Soleus PE GP, SCM and Soleus GP disclaims beneficial ownership of these shares held by Soleus PE other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The number of shares reported in the table above consists of presently exercisable warrants to purchase up to 195,976 shares of Common Stock.
(3) The percentage set forth in row 11 is calculated based upon 15,743,916 shares of Common Stock outstanding as of February 25, 2026, as set forth in the Form 10-K.
SCHEDULE 13G
CUSIP Number(s):
38942Q202
1
Names of Reporting Persons
Soleus PE GP III, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
195,976.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
195,976.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
195,976.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.2 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus PE. Soleus PE GP is the sole general partner of Soleus PE, Soleus PE GP III, LLC is the sole manager of Soleus PE GP, SCM is the investment manager for Soleus PE and for Master Fund, and Soleus GP is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP III, LLC and Soleus GP. Each of Mr. Levy, Soleus PE GP III, LLC, Soleus PE GP, SCM and Soleus GP disclaims beneficial ownership of these shares held by Soleus PE other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The number of shares reported in the table above consists of presently exercisable warrants to purchase up to 195,976 shares of Common Stock.
(3) The percentage set forth in row 11 is calculated based upon 15,743,916 shares of Common Stock outstanding as of February 25, 2026, as set forth in the Form 10-K.
SCHEDULE 13G
CUSIP Number(s):
38942Q202
1
Names of Reporting Persons
Soleus Capital Master Fund, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
195,976.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
195,976.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
195,976.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.2 %
12
Type of Reporting Person (See Instructions)
FI
Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital, LLC is the sole general partner of Master Fund, Soleus Capital Group, LLC ("SCG") is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Soleus PE and for Master Fund, and Soleus GP is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and Soleus GP. Each of SCG, Soleus Capital, LLC, SCM, Soleus GP and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2),The number of shares reported in the table above consists of presently exercisable warrants to purchase up to 195,976 shares of Common Stock.
(3) The percentage set forth in row 11 is calculated based upon 15,743,916 shares of Common Stock outstanding as of February 25, 2026, as set forth in the Form 10-K.
SCHEDULE 13G
CUSIP Number(s):
38942Q202
1
Names of Reporting Persons
Soleus Capital, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
195,976.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
195,976.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
195,976.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.2 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital, LLC is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Soleus PE and for Master Fund, and Soleus GP is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and Soleus GP. Each of SCG, Soleus Capital, LLC, SCM, Soleus GP and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The number of shares reported in the table above consists of presently exercisable warrants to purchase up to 195,976 shares of Common Stock.
(3) The percentage set forth in row 11 is calculated based upon 15,743,916 shares of Common Stock outstanding as of February 25, 2026, as set forth in the Form 10-K.
SCHEDULE 13G
CUSIP Number(s):
38942Q202
1
Names of Reporting Persons
Soleus Capital Group, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
195,976.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
195,976.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
195,976.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.2 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital, LLC is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Soleus PE and for Master Fund, and Soleus GP is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and Soleus GP. Each of SCG, Soleus Capital, LLC, SCM, Soleus GP and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The number of shares reported in the table above consists of presently exercisable warrants to purchase up to 195,976 shares of Common Stock.
(3) The percentage set forth in row 11 is calculated based upon 15,743,916 shares of Common Stock outstanding as of February 25, 2026, as set forth in the Form 10-K.
SCHEDULE 13G
CUSIP Number(s):
38942Q202
1
Names of Reporting Persons
Soleus Capital Management, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
391,952.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
391,952.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
391,952.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
2.4 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus PE and by Master Fund. Soleus PE GP is the sole general partner of Soleus PE, Soleus PE GP III, LLC is the sole manager of Soleus PE GP, SCM is the investment manager for Soleus PE, and Soleus GP is the sole general partner of SCM. Soleus Capital, LLC is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Master Fund, and Soleus GP is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP III, LLC, SCG and Soleus GP. Each of Soleus PE GP, Soleus PE GP III, LLC, Soleus Capital, LLC, SCG, SCM, Soleus GP and Mr. Levy disclaims beneficial ownership of these shares held directly by Soleus PE and Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The number of shares reported in the table above consists of presently exercisable warrants to purchase up to 391,952 shares of Common Stock.
(3) The percentage set forth in row 11 is calculated based upon 15,743,916 shares of Common Stock outstanding as of February 25, 2026, as set forth in the Form 10-K.
SCHEDULE 13G
CUSIP Number(s):
38942Q202
1
Names of Reporting Persons
Soleus GP, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
391,952.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
391,952.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
391,952.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
2.4 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus PE and by Master Fund. Soleus PE GP is the sole general partner of Soleus PE, Soleus PE GP III, LLC is the sole manager of Soleus PE GP, SCM is the investment manager for Soleus PE, and Soleus GP is the sole general partner of SCM. Soleus Capital, LLC is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Master Fund, and Soleus GP is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP III, LLC, SCG and Soleus GP. Each of Soleus PE GP, Soleus PE GP III, LLC, Soleus Capital, LLC, SCG, SCM, Soleus GP and Mr. Levy disclaims beneficial ownership of these shares held directly by Soleus PE and Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The number of shares reported in the table above consists of presently exercisable warrants to purchase up to 391,952 shares of Common Stock.
(3) The percentage set forth in row 11 is calculated based upon 15,743,916 shares of Common Stock outstanding as of February 25, 2026, as set forth in the Form 10-K.
SCHEDULE 13G
CUSIP Number(s):
38942Q202
1
Names of Reporting Persons
Guy Levy
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
391,952.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
391,952.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
391,952.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
2.4 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus PE and by Master Fund. Soleus PE GP is the sole general partner of Soleus PE, Soleus PE GP III, LLC is the sole manager of Soleus PE GP, SCM is the investment manager for Soleus PE, and Soleus GP is the sole general partner of SCM. Soleus Capital, LLC is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Master Fund, and Soleus GP is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP III, LLC, SCG and Soleus GP. Each of Soleus PE GP, Soleus PE GP III, LLC, Soleus Capital, LLC, SCG, SCM, Soleus GP and Mr. Levy disclaims beneficial ownership of these shares held directly by Soleus PE and Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The number of shares reported in the table above consists of presently exercisable warrants to purchase up to 391,952 shares of Common Stock.
(3) The percentage set forth in row 11 is calculated based upon 15,743,916 shares of Common Stock outstanding as of February 25, 2026, as set forth in the Form 10-K.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
CALCIMEDICA, INC.
(b)
Address of issuer's principal executive offices:
505 Coast Boulevard South, Suite 307, La Jolla, CA 92037
Item 2.
(a)
Name of person filing:
Soleus Private Equity GP III, LLC
Soleus Private Equity Fund III, L.P.
Soleus PE GP III, LLC
Soleus Capital Master Fund, L.P.
Soleus Capital, LLC
Soleus Capital Group, LLC
Soleus Capital Management, L.P.
Soleus GP, LLC
Guy Levy
(b)
Address or principal business office or, if none, residence:
Soleus Private Equity GP III, LLC, 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus Private Equity Fund III, L.P., 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus PE GP III, LLC, 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus Capital Master Fund, L.P., 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus Capital, LLC, 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus Capital Group, LLC, 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus Capital Management, L.P., 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus GP, LLC, 100 Field Point Road, Suite 200, Greenwich, CT 06830
Guy Levy, c/o Soleus Capital Management, L.P. 100 Field Point Road, Suite 200, Greenwich, CT 06830
(c)
Citizenship:
Soleus Private Equity GP III, LLC - Delaware
Soleus Private Equity Fund III, L.P. - Delaware
Soleus PE GP III, LLC - Delaware
Soleus Capital Master Fund, L.P. - Cayman Islands
Soleus Capital, LLC - Delaware
Soleus Capital Group, LLC - Delaware
Soleus Capital Management, L.P. - Delaware
Soleus GP, LLC - Delaware
Guy Levy - United States
(d)
Title of class of securities:
Common Stock, par value $0.0001 per share
(e)
CUSIP No.:
38942Q202
Item 4.
Ownership
(a)
Amount beneficially owned:
The information in rows 5 through 9 and 11 on the cover pages to this Schedule 13G, including the footnotes thereto, is hereby incorporated by reference.
Soleus Private Equity GP III, LLC - 195,976
Soleus Private Equity Fund III, L.P. - 195,976
Soleus PE GP III, LLC - 195,976
Soleus Capital Master Fund, L.P. - 195,976
Soleus Capital, LLC - 195,976
Soleus Capital Group, LLC - 195,976
Soleus Capital Management, L.P. - 391,952
Soleus GP, LLC - 391,952
Guy Levy - 391,952
(b)
Percent of class:
Soleus Private Equity GP III, LLC - 1.2%
Soleus Private Equity Fund III, L.P. - 1.2%
Soleus PE GP III, LLC - 1.2%
Soleus Capital Master Fund, L.P. - 1.2%
Soleus Capital, LLC - 1.2%
Soleus Capital Group, LLC - 1.2%
Soleus Capital Management, L.P. - 2.4%
Soleus GP, LLC - 2.4%
Guy Levy - 2.4%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
Soleus Private Equity GP III, LLC - 195,976
Soleus Private Equity Fund III, L.P. - 195,976
Soleus PE GP III, LLC - 195,976
Soleus Capital Master Fund, L.P. - 195,976
Soleus Capital, LLC - 195,976
Soleus Capital Group, LLC - 195,976
Soleus Capital Management, L.P. - 391,952
Soleus GP, LLC - 391,952
Guy Levy - 391,952
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
Soleus Private Equity GP III, LLC - 195,976
Soleus Private Equity Fund III, L.P. - 195,976
Soleus PE GP III, LLC - 195,976
Soleus Capital Master Fund, L.P. - 195,976
Soleus Capital, LLC - 195,976
Soleus Capital Group, LLC - 195,976
Soleus Capital Management, L.P. - 391,952
Soleus GP, LLC - 391,952
Guy Levy - 391,952
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Soleus Private Equity Fund III, L.P.
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy / Managing Member of the Sole Manager of the General Partner of Soleus Private Equity Fund III, L.P.
Date:
05/08/2026
Soleus Private Equity GP III, LLC
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy / Managing Member of the Sole Manager of Soleus Private Equity GP III, LLC
Date:
05/08/2026
Soleus PE GP III, LLC
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy / Managing Member
Date:
05/08/2026
Soleus Capital Master Fund, L.P.
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy / Managing Member of the Managing Member of the General Partner of Soleus Capital Master Fund, L.P.
Date:
05/08/2026
Soleus Capital, LLC
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy / Managing Member of the Managing Member of Soleus Capital, LLC
Date:
05/08/2026
Soleus Capital Group, LLC
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy / Managing Member
Date:
05/08/2026
Soleus Capital Management, L.P.
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy / Managing Member of the General Partner of Soleus Capital Management, L.P.
